Abstract

Castleman disease (CD) is a disorder characterized by lymphoid proliferation. It is not usually the first differential for pyrexia of unknown origin (PUO) because of the extremely rare incidence worldwide. We report the case of a 24-year-old man with PUO for six months. He had been previously investigated for infective, rheumatological, and immunological causes. Extrapulmonary tuberculosis was considered as the most likely diagnosis because of his clinical presentation and locality. Based on this, he was given a trial of anti-tuberculous therapy. However, he did not show any signs of improvement despite being compliant with the medications. His condition was further complicated by the development of ascites. Upon treatment failure, the patient presented to our tertiary care hospital and was investigated for a possible revision of diagnosis. Based on clinical assessment and histopathology of the lymph nodes, he was diagnosed with idiopathic multicentric CD overlapping with systemic lupus erythematosus. He was started on azathioprine and prednisone and showed a positive response, indicated by a decreasing erythrocyte sedimentation rate and C-reactive protein. The patient continues to be healthy and in remission to date.

Highlights

  • In clinical practice, disease manifestations are quite complex with a tremendous overlap

  • Castleman disease (CD) is a disorder characterized by lymphoid proliferation

  • We report the case of a 24-year-old man with pyrexia of unknown origin (PUO) for six months

Read more

Summary

A Case of Castleman Disease: A Diagnostic Dilemma

Ghulam Rabbani Anwar 1 , Muhammad Tariq Mehr 1 , Danial Tahir 2 , Sidra Humayun 3 , Ghulam Farooq 1. 1. Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK 2.

Introduction
Discussion
Conclusions
Disclosures
Simpson D
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.